| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | coumarin 7-hydroxylase activity | 4.86e-07 | 3 | 158 | 3 | GO:0008389 | |
| GeneOntologyMolecularFunction | spectrin binding | 6.73e-06 | 34 | 158 | 5 | GO:0030507 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | FLNA FLNB FLNC SHROOM3 ANK2 SYNM MYO9B WASHC1 ARFGEF2 LMTK2 GBP2 GBP3 NEB SHROOM2 SHANK3 KIF20B ADD3 SETD2 TTLL4 DLEC1 CAMSAP2 EPB41 | 5.58e-05 | 1099 | 158 | 22 | GO:0008092 |
| GeneOntologyMolecularFunction | actin binding | FLNA FLNB FLNC SHROOM3 MYO9B WASHC1 GBP2 GBP3 NEB SHROOM2 SHANK3 ADD3 EPB41 | 1.16e-04 | 479 | 158 | 13 | GO:0003779 |
| GeneOntologyMolecularFunction | actin filament binding | 4.61e-04 | 227 | 158 | 8 | GO:0051015 | |
| GeneOntologyBiologicalProcess | establishment of Sertoli cell barrier | 2.22e-05 | 8 | 154 | 3 | GO:0097368 | |
| GeneOntologyBiologicalProcess | cytolysis in another organism | 3.32e-05 | 9 | 154 | 3 | GO:0051715 | |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 4.71e-05 | 10 | 154 | 3 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 4.71e-05 | 10 | 154 | 3 | GO:0009804 | |
| GeneOntologyBiologicalProcess | actin filament-based process | TNIK FLNA FLNB FLNC SHROOM3 ANK2 MYO9B WASHC1 NEB SHROOM2 NPHP4 SHANK3 SH3D21 ARHGEF10L ADD3 HMCN1 KCNJ8 AKAP13 EPB41 | 5.15e-05 | 912 | 154 | 19 | GO:0030029 |
| GeneOntologyBiologicalProcess | cytolysis | 8.55e-05 | 12 | 154 | 3 | GO:0019835 | |
| GeneOntologyBiologicalProcess | blastocyst growth | 1.03e-04 | 33 | 154 | 4 | GO:0001832 | |
| GeneOntologyCellularComponent | cell cortex | FLNA FLNB SHROOM3 MYO9B TRPC4 WASHC1 SHROOM2 ADD3 STXBP1 HMCN1 AKAP13 DYNC1H1 EPB41 PDZD4 | 7.86e-07 | 371 | 156 | 14 | GO:0005938 |
| GeneOntologyCellularComponent | costamere | 1.97e-05 | 22 | 156 | 4 | GO:0043034 | |
| GeneOntologyCellularComponent | symmetric synapse | 1.10e-04 | 13 | 156 | 3 | GO:0032280 | |
| GeneOntologyCellularComponent | chromocenter | 3.06e-04 | 18 | 156 | 3 | GO:0010369 | |
| GeneOntologyCellularComponent | symmetric, GABA-ergic, inhibitory synapse | 3.29e-04 | 4 | 156 | 2 | GO:0098983 | |
| GeneOntologyCellularComponent | PR-DUB complex | 3.29e-04 | 4 | 156 | 2 | GO:0035517 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | 4.19e-04 | 129 | 156 | 6 | GO:0030863 | |
| GeneOntologyCellularComponent | supramolecular fiber | FLNA CYP2A6 FLNB CYP2A7 FLNC CYP2A13 SHROOM3 ANK2 SYNM MYO9B ARFGEF2 CMYA5 NEB SHROOM2 KIF20B KCNJ8 TTLL4 AKAP13 CAMSAP2 DYNC1H1 | 5.03e-04 | 1179 | 156 | 20 | GO:0099512 |
| GeneOntologyCellularComponent | growth cone | 5.19e-04 | 245 | 156 | 8 | GO:0030426 | |
| GeneOntologyCellularComponent | supramolecular polymer | FLNA CYP2A6 FLNB CYP2A7 FLNC CYP2A13 SHROOM3 ANK2 SYNM MYO9B ARFGEF2 CMYA5 NEB SHROOM2 KIF20B KCNJ8 TTLL4 AKAP13 CAMSAP2 DYNC1H1 | 5.48e-04 | 1187 | 156 | 20 | GO:0099081 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | TNIK FLNA RANBP2 ANK2 UACA MYO9B VPS50 ARFGEF2 LMTK2 GBP2 GBP3 CMYA5 KIF20B STXBP1 PTPRM AKAP13 EIF2AK3 | 6.25e-04 | 934 | 156 | 17 | GO:0048471 |
| GeneOntologyCellularComponent | site of polarized growth | 6.41e-04 | 253 | 156 | 8 | GO:0030427 | |
| GeneOntologyCellularComponent | host intracellular region | 8.14e-04 | 6 | 156 | 2 | GO:0043656 | |
| GeneOntologyCellularComponent | host cell cytoplasm | 8.14e-04 | 6 | 156 | 2 | GO:0030430 | |
| GeneOntologyCellularComponent | host cell part | 8.14e-04 | 6 | 156 | 2 | GO:0033643 | |
| GeneOntologyCellularComponent | host intracellular part | 8.14e-04 | 6 | 156 | 2 | GO:0033646 | |
| GeneOntologyCellularComponent | host cell cytoplasm part | 8.14e-04 | 6 | 156 | 2 | GO:0033655 | |
| GeneOntologyCellularComponent | symbiont-containing vacuole | 8.14e-04 | 6 | 156 | 2 | GO:0020003 | |
| GeneOntologyCellularComponent | symbiont-containing vacuole membrane | 8.14e-04 | 6 | 156 | 2 | GO:0020005 | |
| GeneOntologyCellularComponent | Z disc | 9.60e-04 | 151 | 156 | 6 | GO:0030018 | |
| GeneOntologyCellularComponent | myofibril | 1.05e-03 | 273 | 156 | 8 | GO:0030016 | |
| GeneOntologyCellularComponent | nuclear body | AMER1 SETX BMP2K ZCCHC8 ICE1 CMYA5 NPHP4 REXO1 TINF2 CCNB3 CDK13 SGO2 ZNF830 TAB1 SNAPC2 EPB41 | 1.20e-03 | 903 | 156 | 16 | GO:0016604 |
| GeneOntologyCellularComponent | symbiont cell surface | 1.50e-03 | 8 | 156 | 2 | GO:0106139 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.54e-03 | 290 | 156 | 8 | GO:0043292 | |
| GeneOntologyCellularComponent | I band | 1.56e-03 | 166 | 156 | 6 | GO:0031674 | |
| GeneOntologyCellularComponent | other organism part | 1.92e-03 | 9 | 156 | 2 | GO:0044217 | |
| GeneOntologyCellularComponent | cyclin/CDK positive transcription elongation factor complex | 1.92e-03 | 9 | 156 | 2 | GO:0008024 | |
| GeneOntologyCellularComponent | sarcomere | 2.71e-03 | 249 | 156 | 7 | GO:0030017 | |
| GeneOntologyCellularComponent | cytoplasmic microtubule | 3.24e-03 | 133 | 156 | 5 | GO:0005881 | |
| Domain | Cyt_P450_E_grp-I_CYP2A-like | 2.41e-06 | 4 | 159 | 3 | IPR008067 | |
| Domain | - | ANK2 UACA TRPC4 ANKRD30B ANKRD20A2P ANKRD20A3P SHANK3 KIDINS220 ANKRD20A4P AKAP13 ANKRD20A1 | 9.30e-06 | 248 | 159 | 11 | 1.25.40.20 |
| Domain | Ankyrin_rpt-contain_dom | ANK2 UACA TRPC4 ANKRD30B ANKRD20A2P ANKRD20A3P SHANK3 KIDINS220 ANKRD20A4P AKAP13 ANKRD20A1 | 1.16e-05 | 254 | 159 | 11 | IPR020683 |
| Domain | ANK | ANK2 UACA TRPC4 ANKRD30B ANKRD20A2P ANKRD20A3P SHANK3 KIDINS220 ANKRD20A4P ANKRD20A1 | 5.94e-05 | 251 | 159 | 10 | SM00248 |
| Domain | ANK_REPEAT | ANK2 UACA TRPC4 ANKRD30B ANKRD20A2P ANKRD20A3P SHANK3 KIDINS220 ANKRD20A4P ANKRD20A1 | 6.35e-05 | 253 | 159 | 10 | PS50088 |
| Domain | ANK_REP_REGION | ANK2 UACA TRPC4 ANKRD30B ANKRD20A2P ANKRD20A3P SHANK3 KIDINS220 ANKRD20A4P ANKRD20A1 | 6.56e-05 | 254 | 159 | 10 | PS50297 |
| Domain | IG_FLMN | 6.95e-05 | 10 | 159 | 3 | SM00557 | |
| Domain | RBB1NT | 7.20e-05 | 2 | 159 | 2 | PF08169 | |
| Domain | RBB1NT | 7.20e-05 | 2 | 159 | 2 | IPR012603 | |
| Domain | NLGN4 | 7.20e-05 | 2 | 159 | 2 | IPR030025 | |
| Domain | Ankyrin_rpt | ANK2 UACA TRPC4 ANKRD30B ANKRD20A2P ANKRD20A3P SHANK3 KIDINS220 ANKRD20A4P ANKRD20A1 | 8.49e-05 | 262 | 159 | 10 | IPR002110 |
| Domain | Filamin | 9.50e-05 | 11 | 159 | 3 | PF00630 | |
| Domain | GFP-like | 9.50e-05 | 11 | 159 | 3 | IPR023413 | |
| Domain | FILAMIN_REPEAT | 9.50e-05 | 11 | 159 | 3 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 9.50e-05 | 11 | 159 | 3 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 9.50e-05 | 11 | 159 | 3 | IPR017868 | |
| Domain | - | 9.50e-05 | 11 | 159 | 3 | 2.40.155.10 | |
| Domain | Ank_2 | ANK2 UACA ANKRD30B ANKRD20A2P ANKRD20A3P SHANK3 KIDINS220 ANKRD20A4P ANKRD20A1 | 9.61e-05 | 215 | 159 | 9 | PF12796 |
| Domain | Ank | ANK2 UACA TRPC4 ANKRD30B ANKRD20A2P ANKRD20A3P KIDINS220 ANKRD20A4P ANKRD20A1 | 1.50e-04 | 228 | 159 | 9 | PF00023 |
| Domain | HARE-HTH | 2.15e-04 | 3 | 159 | 2 | PF05066 | |
| Domain | ASXH | 2.15e-04 | 3 | 159 | 2 | PF13919 | |
| Domain | PHD_3 | 2.15e-04 | 3 | 159 | 2 | PF13922 | |
| Domain | ASX-like_PHD | 2.15e-04 | 3 | 159 | 2 | IPR026905 | |
| Domain | ASXH | 2.15e-04 | 3 | 159 | 2 | IPR028020 | |
| Domain | ASD1 | 2.15e-04 | 3 | 159 | 2 | PF08688 | |
| Domain | ASD1_dom | 2.15e-04 | 3 | 159 | 2 | IPR014800 | |
| Domain | ASX/ASX-like | 2.15e-04 | 3 | 159 | 2 | IPR024811 | |
| Domain | HB1/Asxl_HTH | 2.15e-04 | 3 | 159 | 2 | IPR007759 | |
| Domain | ASD1 | 2.15e-04 | 3 | 159 | 2 | PS51306 | |
| Domain | Shroom_fam | 4.27e-04 | 4 | 159 | 2 | IPR027685 | |
| Domain | ASD2_dom | 4.27e-04 | 4 | 159 | 2 | IPR014799 | |
| Domain | ASD2 | 4.27e-04 | 4 | 159 | 2 | PF08687 | |
| Domain | ASD2 | 4.27e-04 | 4 | 159 | 2 | PS51307 | |
| Domain | Nlgn | 7.08e-04 | 5 | 159 | 2 | IPR000460 | |
| Domain | ACTININ_2 | 9.46e-04 | 23 | 159 | 3 | PS00020 | |
| Domain | ACTININ_1 | 9.46e-04 | 23 | 159 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 9.46e-04 | 23 | 159 | 3 | IPR001589 | |
| Domain | Tudor-knot | 1.06e-03 | 6 | 159 | 2 | PF11717 | |
| Domain | Tudor-knot | 1.06e-03 | 6 | 159 | 2 | IPR025995 | |
| Pathway | WP_NPHP1_DELETION_SYNDROME | 9.21e-07 | 11 | 105 | 4 | M48099 | |
| Pathway | REACTOME_CYP2E1_REACTIONS | 6.34e-05 | 11 | 105 | 3 | M27130 | |
| Pathway | REACTOME_CYP2E1_REACTIONS | 8.41e-05 | 12 | 105 | 3 | MM14847 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 8.90e-05 | 32 | 105 | 4 | MM15326 | |
| Pubmed | TET2 FLNA FLNB RANBP2 ZNF280D ZCCHC8 ICE1 RBBP8NL JMJD1C KIF20B GREB1L ZNF608 ZNF644 BRD4 DOCK7 CHD6 CRYBG3 | 1.31e-11 | 418 | 161 | 17 | 34709266 | |
| Pubmed | TNIK ASXL1 ZHX2 CSDE1 USP8 KIDINS220 TBC1D1 ZNF644 DOCK7 CHD6 ASXL2 HERC3 SPEN CAMSAP2 DYNC1H1 | 8.57e-10 | 407 | 161 | 15 | 12693553 | |
| Pubmed | 2.20e-09 | 5 | 161 | 4 | 12006559 | ||
| Pubmed | FLNA POLR2A GPRIN1 JMJD1C ADD3 CSDE1 SETD2 UBA1 SCML2 STRAP BRD4 DOCK7 TAB1 SPEN DYNC1H1 EPB41 | 6.58e-09 | 549 | 161 | 16 | 38280479 | |
| Pubmed | SHROOM3 AMER1 SETX BMP2K SYNM APBB2 ARFGEF2 RNF213 GPRIN1 CLCC1 ADD3 KIDINS220 DOCK7 DCLRE1A SPEN DYNC1H1 EPB41 CDON | 2.47e-08 | 777 | 161 | 18 | 35844135 | |
| Pubmed | TET2 FLNB ANK2 SYNM ZCCHC8 TMEM59 APBB2 ARFGEF2 RPS24 CMYA5 SHROOM2 PREPL MOAP1 ADD3 JAK1 CSDE1 TRIM66 USP8 HEATR6 STXBP1 SCG3 CHD6 DYNC1H1 | 3.04e-08 | 1285 | 161 | 23 | 35914814 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 3.96e-08 | 202 | 161 | 10 | 33005030 | |
| Pubmed | MBTD1 ZBTB2 ARID4B UACA ZCCHC8 POLR2A VPS50 FBRSL1 PER1 RNF213 ZNF518A JAK1 TRIM66 SETD2 ZNF469 SF3B3 ZNF608 CCNB3 BRD4 RARS2 CRYBG3 | 5.57e-08 | 1116 | 161 | 21 | 31753913 | |
| Pubmed | FLNA CYP2A6 FLNB FLNC RANBP2 CYP2A13 AMER1 ANK2 TMEM135 ANKRD30B NEB SH3D21 USP8 SF3B3 STXBP1 ZNF608 CDK13 SCG3 CHD6 DLEC1 OTUD3 SPEN CAMSAP2 RPL3L | 5.77e-08 | 1442 | 161 | 24 | 35575683 | |
| Pubmed | TNIK FLNA FLNB RANBP2 ANK2 PER1 LMTK2 RPS24 GPRIN1 SHROOM2 SHANK3 ADD3 CSDE1 UBA1 STXBP1 PPA2 DOCK7 TAB1 CRYBG3 CAMSAP2 EPB41 | 7.84e-08 | 1139 | 161 | 21 | 36417873 | |
| Pubmed | ZBTB2 UACA SYNM PER1 RNF213 NPHP4 JMJD1C SHANK3 REXO1 TRIM66 SETD2 CDK13 MINAR1 KLHDC10 | 8.32e-08 | 493 | 161 | 14 | 15368895 | |
| Pubmed | Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition. | 9.74e-08 | 3 | 161 | 3 | 31645370 | |
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 8297477 | ||
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 8188299 | ||
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 8250953 | ||
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 2703500 | ||
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 22217847 | ||
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 12393796 | ||
| Pubmed | Differential distribution of CYP2A6 and CYP2A13 in the human respiratory tract. | 9.74e-08 | 3 | 161 | 3 | 22890016 | |
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 11153914 | ||
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 11252955 | ||
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 3346244 | ||
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 2733794 | ||
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 8484736 | ||
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 1417950 | ||
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 24045421 | ||
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 32987105 | ||
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 2765478 | ||
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 2415518 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | FLNB SHROOM3 URI1 AMER1 MAOA UACA NLGN4Y FBRSL1 APBB2 RNF213 RBBP8NL ZHX2 SHROOM2 JMJD1C CLCC1 SLC35F5 CSDE1 KIDINS220 ZNF608 CDK13 TBC1D1 AKAP13 CHD6 EPB41 | 1.04e-07 | 1489 | 161 | 24 | 28611215 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | FLNA RANBP2 SETX ARID4B ARID4A POLR2A ICE1 JMJD1C KIF20B SETD2 SCML2 SF3B3 TINF2 ZNF644 BRD4 SGO2 ZNF830 SPEN EPB41 | 1.06e-07 | 954 | 161 | 19 | 36373674 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | ASXL1 FLNC MBTD1 RANBP2 ZBTB2 SETX ARID4B ARID4A MYO9B POLR2A PER1 JMJD1C ZNF644 ASXL2 SPEN EIF2AK3 DYNC1H1 ANKRD20A1 | 1.07e-07 | 857 | 161 | 18 | 25609649 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FLNA RANBP2 ARID4B UACA ARID4A ZCCHC8 POLR2A ARFGEF2 GPRIN1 REXO1 SETD2 UBA1 SCML2 CDK13 ZNF644 BRD4 SPEN | 1.32e-07 | 774 | 161 | 17 | 15302935 |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | FLNC RANBP2 AMER1 PER1 UBA1 ZNF644 DOCK7 AKAP13 HERC3 DYNC1H1 | 1.45e-07 | 232 | 161 | 10 | 25515538 |
| Pubmed | FLNB RANBP2 ANK2 RPS24 GPRIN1 JMJD1C CLCC1 CSDE1 UBA1 SF3B3 KIDINS220 DOCK7 CRYBG3 EIF2AK3 DYNC1H1 EPB41 | 2.16e-07 | 708 | 161 | 16 | 39231216 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FLNA FLNC SHROOM3 MYO9B POLR2A FBRSL1 PER1 ARFGEF2 LMTK2 ICE1 NPHP4 REXO1 ARHGEF10L CDK13 BRD4 TTLL4 PPA2 AKAP13 SPEN DYNC1H1 | 2.20e-07 | 1105 | 161 | 20 | 35748872 |
| Pubmed | TNIK CLGN POLR2A VPS50 RNF213 ICE1 JMJD1C CLCC1 USP8 SETD2 SCML2 STRAP TTLL4 AKAP13 DCLRE1A CHD6 | 3.42e-07 | 733 | 161 | 16 | 34672954 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | FLNA FLNB RANBP2 SYNM POLR2A JMJD1C CSDE1 KIDINS220 DYNC1H1 EPB41 | 3.59e-07 | 256 | 161 | 10 | 33397691 |
| Pubmed | 3.88e-07 | 4 | 161 | 3 | 10490589 | ||
| Pubmed | Two steroid 15 alpha-hydroxylase genes and a homologous gene family in mice. | 3.88e-07 | 4 | 161 | 3 | 1970547 | |
| Pubmed | 3.88e-07 | 4 | 161 | 3 | 11739414 | ||
| Pubmed | Structural interaction and functional regulation of polycystin-2 by filamin. | 3.88e-07 | 4 | 161 | 3 | 22802962 | |
| Pubmed | Oncogenic Truncations of ASXL1 Enhance a Motif for BRD4 ET-Domain Binding. | 3.88e-07 | 4 | 161 | 3 | 34536441 | |
| Pubmed | 3.88e-07 | 4 | 161 | 3 | 9408084 | ||
| Pubmed | 3.88e-07 | 4 | 161 | 3 | 7565685 | ||
| Pubmed | TNIK FLNA FLNB ASXL1 FLNC ANK2 SHROOM2 SHANK3 CSDE1 BRD4 SPEN | 4.34e-07 | 329 | 161 | 11 | 17474147 | |
| Pubmed | 7.37e-07 | 277 | 161 | 10 | 30745168 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | TET2 MBTD1 RANBP2 ARID4B ARID4A FBRSL1 ZHX2 ZNF608 ZNF644 ASXL2 SPEN | 8.19e-07 | 351 | 161 | 11 | 38297188 |
| Pubmed | 9.67e-07 | 5 | 161 | 3 | 17360453 | ||
| Pubmed | 9.67e-07 | 5 | 161 | 3 | 19366992 | ||
| Pubmed | 1.00e-06 | 17 | 161 | 4 | 27197076 | ||
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | TNIK UACA TMEM237 GPRIN1 ADD3 JAK1 KIDINS220 STXBP1 PTPRM DOCK7 EPB41 | 1.64e-06 | 377 | 161 | 11 | 38117590 |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | TNIK URI1 AMER1 BMP2K ZCCHC8 POLR2A FBRSL1 PER1 C2orf68 ADD3 CSDE1 SETD2 STRAP TTLL4 DOCK7 TAB1 SNAPC2 CAMSAP2 | 1.70e-06 | 1038 | 161 | 18 | 26673895 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TNIK FLNA RANBP2 ANK2 ZCCHC8 POLR2A ICE1 GPRIN1 ADD3 CSDE1 USP8 SETD2 UBA1 SCML2 STRAP CAMSAP2 EPB41 | 1.76e-06 | 934 | 161 | 17 | 33916271 |
| Pubmed | 1.93e-06 | 6 | 161 | 3 | 7668294 | ||
| Pubmed | 1.93e-06 | 6 | 161 | 3 | 21757726 | ||
| Pubmed | 1.93e-06 | 6 | 161 | 3 | 17293456 | ||
| Pubmed | 1.93e-06 | 6 | 161 | 3 | 8587134 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | MBTD1 RANBP2 SETX ARID4B TMEM237 ARID4A ZCCHC8 POLR2A JMJD1C SETD2 SCML2 SF3B3 TINF2 CDK13 ZNF644 BRD4 DCLRE1A CHD6 ASXL2 SPEN | 2.52e-06 | 1294 | 161 | 20 | 30804502 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TET2 SHROOM3 AMER1 SETX ZCCHC8 LMTK2 FSIP2 USP8 TBC1D1 BRD4 DOCK7 AKAP13 TAB1 CRYBG3 CAMSAP2 EPB41 | 2.77e-06 | 861 | 161 | 16 | 36931259 |
| Pubmed | 3.22e-06 | 255 | 161 | 9 | 15324660 | ||
| Pubmed | 3.36e-06 | 7 | 161 | 3 | 9630227 | ||
| Pubmed | 3.36e-06 | 7 | 161 | 3 | 14630516 | ||
| Pubmed | 3.36e-06 | 7 | 161 | 3 | 16076904 | ||
| Pubmed | FLNB FLNC MBTD1 RANBP2 COL12A1 ANK2 UACA CMYA5 NEB PREPL JMJD1C SLC35F5 | 3.87e-06 | 497 | 161 | 12 | 23414517 | |
| Pubmed | FLNA FLNB FLNC ZCCHC8 ARFGEF2 SVEP1 ZNF518A CDK13 TBC1D1 BRD4 CHD6 ASXL2 DYNC1H1 | 4.17e-06 | 591 | 161 | 13 | 15231748 | |
| Pubmed | FLNA FLNB ZCCHC8 RPS24 KIF20B ADD3 UBA1 SF3B3 CDK13 BRD4 DOCK7 DYNC1H1 | 4.64e-06 | 506 | 161 | 12 | 30890647 | |
| Pubmed | 5.36e-06 | 8 | 161 | 3 | 2885848 | ||
| Pubmed | MEKK4 signaling regulates filamin expression and neuronal migration. | 5.36e-06 | 8 | 161 | 3 | 17145501 | |
| Pubmed | Expression of testicular germ cell genes identified by differential display analysis. | 5.36e-06 | 8 | 161 | 3 | 12634303 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | SETX ARID4B ZNF280D ARID4A JMJD1C KIF20B FSIP2 SCML2 ZNF644 BRD4 SGO2 CHD6 SPEN | 5.65e-06 | 608 | 161 | 13 | 36089195 |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 5.65e-06 | 146 | 161 | 7 | 23892456 | |
| Pubmed | TET2 SHROOM3 SETX VPS50 FBRSL1 LMTK2 ICE1 PREPL ARHGEF10L SF3B3 ZNF608 TTLL4 | 7.26e-06 | 529 | 161 | 12 | 14621295 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | FLNA FLNC RANBP2 UACA BMP2K CSDE1 UBA1 SCML2 SF3B3 STRAP DOCK7 AKAP13 DCLRE1A SPEN | 7.66e-06 | 724 | 161 | 14 | 36232890 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | FLNA FLNC RANBP2 SETX ZHX2 JMJD1C ADD3 CSDE1 UBA1 ZNF608 TAB1 | 7.78e-06 | 444 | 161 | 11 | 34795231 |
| Pubmed | 7.90e-06 | 101 | 161 | 6 | 10997877 | ||
| Pubmed | 8.01e-06 | 9 | 161 | 3 | 37838304 | ||
| Pubmed | 8.01e-06 | 9 | 161 | 3 | 11807098 | ||
| Pubmed | 8.01e-06 | 9 | 161 | 3 | 23010509 | ||
| Pubmed | Feedback regulation of transcriptional termination by the mammalian circadian clock PERIOD complex. | 8.01e-06 | 9 | 161 | 3 | 22767893 | |
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 9.35e-06 | 104 | 161 | 6 | 31240132 | |
| Pubmed | 9.85e-06 | 371 | 161 | 10 | 15747579 | ||
| Pubmed | ASXL3 bridges BRD4 to BAP1 complex and governs enhancer activity in small cell lung cancer. | 1.14e-05 | 10 | 161 | 3 | 32669118 | |
| Pubmed | FLNA FLNB MBTD1 AMER1 SETX BMP2K LMTK2 SALL4 RPS24 SHROOM2 ESCO2 SCML2 KCNJ8 VCAN TTLL4 ASXL2 KLHDC10 | 1.25e-05 | 1084 | 161 | 17 | 11544199 | |
| Pubmed | RANBP2 SETX TRIM75 ZCCHC8 SALL4 STRAP CDK13 BRD4 CHD6 SPEN HYDIN | 1.30e-05 | 469 | 161 | 11 | 27634302 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | TNIK ANK2 UACA TMEM237 ARFGEF2 ADD3 KIDINS220 NLGN4X PTPRM NRK DOCK7 EPB41 | 1.50e-05 | 569 | 161 | 12 | 30639242 |
| Pubmed | Guanylate binding proteins promote caspase-11-dependent pyroptosis in response to cytoplasmic LPS. | 1.56e-05 | 11 | 161 | 3 | 24715728 | |
| Pubmed | 1.56e-05 | 11 | 161 | 3 | 36579465 | ||
| Pubmed | Developmental basis for filamin-A-associated myxomatous mitral valve disease. | 1.56e-05 | 11 | 161 | 3 | 22843703 | |
| Pubmed | 1.56e-05 | 11 | 161 | 3 | 26403076 | ||
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 1.67e-05 | 313 | 161 | 9 | 38270169 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | MBTD1 SETX MYO9B ZCCHC8 VPS50 FBRSL1 KIF20B SETD2 SF3B3 ZNF644 CRYBG3 SPEN | 2.07e-05 | 588 | 161 | 12 | 38580884 |
| Pubmed | RANBP2 SHROOM3 SETX UACA BMP2K ZCCHC8 POLR2A ICE1 ZHX2 KIF20B GREB1L CSDE1 SETD2 SCML2 KIDINS220 CDK13 CHD6 SPEN CAMSAP2 EPB41 | 2.12e-05 | 1497 | 161 | 20 | 31527615 | |
| Pubmed | Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo. | 2.13e-05 | 2 | 161 | 2 | 24218140 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 12325023 | ||
| Pubmed | Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemia. | 2.13e-05 | 2 | 161 | 2 | 26771811 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 30876690 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 21395539 | ||
| Pubmed | Species differences in coumarin metabolism: a molecular modelling evaluation of CYP2A interactions. | 2.13e-05 | 2 | 161 | 2 | 12162851 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 1302041 | ||
| Interaction | CYP2A7 interactions | 5.00e-07 | 3 | 161 | 3 | int:CYP2A7 | |
| Interaction | MYBPC2 interactions | 1.49e-06 | 45 | 161 | 6 | int:MYBPC2 | |
| Interaction | PHF21A interactions | FLNA FLNB RANBP2 ZCCHC8 VPS50 ICE1 JMJD1C KIF20B ESCO2 BRD4 DOCK7 CHD6 CRYBG3 | 3.98e-06 | 343 | 161 | 13 | int:PHF21A |
| Interaction | KDM1A interactions | TNIK TET2 FLNA FLNB RANBP2 ZNF280D ZCCHC8 POLR2A VPS50 ICE1 RBBP8NL JMJD1C KIF20B ESCO2 GREB1L ZNF608 ZNF644 BRD4 DOCK7 CHD6 CRYBG3 CCDC33 | 6.07e-06 | 941 | 161 | 22 | int:KDM1A |
| Interaction | LRRC31 interactions | 6.09e-06 | 205 | 161 | 10 | int:LRRC31 | |
| Interaction | ANKRD20A4P interactions | 9.83e-06 | 6 | 161 | 3 | int:ANKRD20A4P | |
| Interaction | RCOR1 interactions | TNIK FLNA RANBP2 ARID4A ZCCHC8 VPS50 ICE1 JMJD1C KIF20B ESCO2 TRIM66 BRD4 DOCK7 CHD6 SPEN | 1.05e-05 | 494 | 161 | 15 | int:RCOR1 |
| Interaction | NUP43 interactions | FLNA RANBP2 SETX ARID4B ZNF280D ARID4A ICE1 ZHX2 JMJD1C ZNF518A FSIP2 SETD2 ZNF608 ZNF644 CHD6 ASXL2 SPEN | 1.11e-05 | 625 | 161 | 17 | int:NUP43 |
| Interaction | DDB1 interactions | TET2 FLNA ASXL1 FLNC ZBTB2 ARID4B POLR2A NPHP4 SHANK3 MOAP1 ESCO2 CSDE1 SETD2 UBA1 STRAP BRD4 ASXL2 DYNC1H1 | 1.22e-05 | 697 | 161 | 18 | int:DDB1 |
| Interaction | PHLPP1 interactions | FLNA FLNB RANBP2 SYNM POLR2A CMYA5 NEB JMJD1C CSDE1 KIDINS220 DYNC1H1 EPB41 | 1.57e-05 | 333 | 161 | 12 | int:PHLPP1 |
| Interaction | ANKRD20A2P interactions | 1.71e-05 | 7 | 161 | 3 | int:ANKRD20A2P | |
| Interaction | SKAP1 interactions | 1.78e-05 | 102 | 161 | 7 | int:SKAP1 | |
| Interaction | SDF4 interactions | 2.94e-05 | 151 | 161 | 8 | int:SDF4 | |
| Interaction | ANKRD20A1 interactions | 7.88e-05 | 11 | 161 | 3 | int:ANKRD20A1 | |
| Interaction | KCTD9 interactions | 8.45e-05 | 225 | 161 | 9 | int:KCTD9 | |
| Interaction | NPHP1 interactions | 8.46e-05 | 130 | 161 | 7 | int:NPHP1 | |
| Interaction | KLF3 interactions | 9.34e-05 | 228 | 161 | 9 | int:KLF3 | |
| Interaction | MAU2 interactions | 1.12e-04 | 136 | 161 | 7 | int:MAU2 | |
| Cytoband | 1p22.2 | 1.30e-04 | 28 | 161 | 3 | 1p22.2 | |
| GeneFamily | Ankyrin repeat domain containing | ANK2 UACA TRPC4 ANKRD30B ANKRD20A2P ANKRD20A3P SHANK3 KIDINS220 ANKRD20A4P ANKRD20A1 | 4.23e-07 | 242 | 92 | 10 | 403 |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 1.35e-05 | 29 | 92 | 4 | 396 | |
| GeneFamily | Cytochrome P450 family 2 | 7.42e-04 | 35 | 92 | 3 | 1001 | |
| GeneFamily | Sterile alpha motif domain containing|MBT domain containing | 9.01e-04 | 9 | 92 | 2 | 1263 | |
| GeneFamily | Fibronectin type III domain containing | 1.35e-03 | 160 | 92 | 5 | 555 | |
| GeneFamily | AT-rich interaction domain containing | 2.58e-03 | 15 | 92 | 2 | 418 | |
| GeneFamily | Wiskott-Aldrich Syndrome protein family | 2.93e-03 | 16 | 92 | 2 | 14 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | FLNB ASXL1 RANBP2 URI1 SETX BMP2K ARID4A MYO9B APBB2 ZHX2 KIF20B SETD2 KIDINS220 PTPRM CDK13 AKAP13 CRYBG3 KLHDC10 SPEN CAMSAP2 | 2.97e-07 | 856 | 160 | 20 | M4500 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | FLNA RANBP2 URI1 SETX ARID4B ARID4A MYO9B GBP2 RNF213 GBP3 ICE1 JMJD1C JAK1 CSDE1 SETD2 SF3B3 KIDINS220 TINF2 CDK13 TBC1D1 ZNF644 AKAP13 ASXL2 SPEN DYNC1H1 | 4.17e-06 | 1492 | 160 | 25 | M40023 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | MBTD1 ZBTB2 URI1 ARID4B ZNF280D ARID4A POLR2A VPS50 ARFGEF2 ICE1 JMJD1C ADD3 CSDE1 STXBP1 ASXL2 | 1.85e-05 | 564 | 156 | 15 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | TET2 SETX ARID4B RNF213 JMJD1C SETD2 CDK13 ZNF644 AKAP13 DYNC1H1 EPB41 | 1.89e-10 | 200 | 161 | 11 | 12f1685ce8f218433068e090c9d839cd5a1910bf |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.62e-09 | 186 | 161 | 10 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | FLNB COL12A1 SETX UACA RNF213 ADD3 STXBP1 HMCN1 ZNF608 PTPRM | 3.26e-09 | 200 | 161 | 10 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | FLNA ARID4B RNF213 JAK1 CSDE1 SETD2 CDK13 AKAP13 DYNC1H1 EPB41 | 3.26e-09 | 200 | 161 | 10 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.40e-08 | 135 | 161 | 8 | 3351e8b9e417397c5fa9f856184ff24ce1a27242 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.04e-08 | 200 | 161 | 9 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.04e-08 | 200 | 161 | 9 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 4.36e-07 | 188 | 161 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.91e-07 | 191 | 161 | 8 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.31e-07 | 193 | 161 | 8 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.53e-07 | 194 | 161 | 8 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 6.95e-07 | 200 | 161 | 8 | 6f531a418ff25b59a543800cf4bce7b72404ce08 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.95e-07 | 200 | 161 | 8 | 2d07237022b409c4fac6fcf99b68c8affb3007cd | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 6.95e-07 | 200 | 161 | 8 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.95e-07 | 200 | 161 | 8 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.95e-07 | 200 | 161 | 8 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 6.95e-07 | 200 | 161 | 8 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.21e-06 | 149 | 161 | 7 | 768877bade04ca0321593b8470b5011ad8270431 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.11e-06 | 162 | 161 | 7 | 810881210e015c788814e4fe8d7a24c929cf2621 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.94e-06 | 178 | 161 | 7 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.56e-06 | 182 | 161 | 7 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.72e-06 | 183 | 161 | 7 | 2f0ee40e69ad1259e56e8ee4b352736900eb8901 | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.72e-06 | 183 | 161 | 7 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 4.72e-06 | 183 | 161 | 7 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-ACTC+_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.90e-06 | 184 | 161 | 7 | 39168ca2bbf1369c9fe87c67f0aaff5e3cd03151 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 4.90e-06 | 184 | 161 | 7 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 5.64e-06 | 188 | 161 | 7 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 6.04e-06 | 190 | 161 | 7 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 6.25e-06 | 191 | 161 | 7 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.47e-06 | 192 | 161 | 7 | 8d56e360ebc624ca4cd7f0af4f3cc599c244f134 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related-FDC|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.92e-06 | 194 | 161 | 7 | f9fbb043411546d8c9e0321a64165d411f44aeb7 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.92e-06 | 194 | 161 | 7 | 439d3f17c1f4736122b330e98add9292c7036a8e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.40e-06 | 196 | 161 | 7 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.40e-06 | 196 | 161 | 7 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 7.65e-06 | 197 | 161 | 7 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 7.91e-06 | 198 | 161 | 7 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 8.17e-06 | 199 | 161 | 7 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.17e-06 | 199 | 161 | 7 | 3a3e2bb21cd0293622b1a975263e918d9ba24265 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.17e-06 | 199 | 161 | 7 | 615f20bf136dfef53b072667cf0e4df6a1017e05 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.17e-06 | 199 | 161 | 7 | 56d72da6a5fab9cbb2975fe6f87a631debaba6a8 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.45e-06 | 200 | 161 | 7 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_3|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.72e-05 | 149 | 161 | 6 | 651494e84be03dc7b061ebdfa91756a1c507b9b4 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.76e-05 | 162 | 161 | 6 | 5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.99e-05 | 173 | 161 | 6 | fc2602b2ce051cd4c33957d7e3d041ff8a529883 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.99e-05 | 173 | 161 | 6 | 901b8e6909c1f3849906fad9cee17b8f0bab050d | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-monocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.12e-05 | 174 | 161 | 6 | 118ba2729ecc6aa1bb8548f3cf537b3f9e902ef0 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.25e-05 | 175 | 161 | 6 | e78bf0c33a741bb97e987e41ac33da9e623a08ec | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.62e-05 | 184 | 161 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.62e-05 | 184 | 161 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.62e-05 | 184 | 161 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.62e-05 | 184 | 161 | 6 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_C|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.14e-05 | 187 | 161 | 6 | 1e8651e6c547384ace5a66b96c6b24a7f390a7ee | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.14e-05 | 187 | 161 | 6 | f5a202d5f8eb57b57d80815ce98774e04c387383 | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 6.33e-05 | 188 | 161 | 6 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 6.33e-05 | 188 | 161 | 6 | 409a7b69d02e87084ca955e3fe6c77230dee8861 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 6.52e-05 | 189 | 161 | 6 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 6.52e-05 | 189 | 161 | 6 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.52e-05 | 189 | 161 | 6 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.52e-05 | 189 | 161 | 6 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 6.52e-05 | 189 | 161 | 6 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 6.71e-05 | 190 | 161 | 6 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 6.71e-05 | 190 | 161 | 6 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 6.71e-05 | 190 | 161 | 6 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 6.91e-05 | 191 | 161 | 6 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 7.11e-05 | 192 | 161 | 6 | 6c106b91e46eabbe686a52a65a9c94ad9cbe9390 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 7.11e-05 | 192 | 161 | 6 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 7.11e-05 | 192 | 161 | 6 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 192 | 161 | 6 | 0dc1f46e40346ed0b286e53b106a812441575100 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.31e-05 | 193 | 161 | 6 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 7.31e-05 | 193 | 161 | 6 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | LPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.53e-05 | 194 | 161 | 6 | 58f069efdefa0366033764446b9d6ffd4a17807e | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.53e-05 | 194 | 161 | 6 | bfd92ec75facb0ba55c31e5f2e089d983b3d0169 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 7.74e-05 | 195 | 161 | 6 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.96e-05 | 196 | 161 | 6 | 2029f58ce6a7b8c35d3a7496c3341391990909ce | |
| ToppCell | Endothelial-Endothelial-F|Endothelial / shred on cell class and cell subclass (v4) | 8.16e-05 | 122 | 161 | 5 | 2cb8bb63c69aed4d4504b9d97219b8707666f950 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.19e-05 | 197 | 161 | 6 | 2744cc94883c5d0424677cf5093bbab622933e9b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.19e-05 | 197 | 161 | 6 | 80e153790cef37b743e22a7370ff5b3a6abf147d | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.19e-05 | 197 | 161 | 6 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 8.19e-05 | 197 | 161 | 6 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.42e-05 | 198 | 161 | 6 | d5990cab01de6e6f3757f5a50ef70ced711bb1fa | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 8.42e-05 | 198 | 161 | 6 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 8.66e-05 | 199 | 161 | 6 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.66e-05 | 199 | 161 | 6 | d9d7f36b4b5592b7855448730044c90997b55499 | |
| ToppCell | healthy_donor-Lymphocytic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 8.66e-05 | 199 | 161 | 6 | 2841e16d54acd344ba454f024e285c28abc37319 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.66e-05 | 199 | 161 | 6 | 9846d6a31635fde759d55674631c11ab9270a603 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.66e-05 | 199 | 161 | 6 | 379bbd9cecf466b902411c54d74bd9885285b1ba | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1--L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.90e-05 | 200 | 161 | 6 | f3c710f0fc8a7bfb5371d1aff6e3d8f266953153 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.90e-05 | 200 | 161 | 6 | fee22a6a6c7b93af204b5b56f2c34f1411500e18 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.90e-05 | 200 | 161 | 6 | a4ec0e80f5422b91b85264a9bb74568dd577e285 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 8.90e-05 | 200 | 161 | 6 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 8.90e-05 | 200 | 161 | 6 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Gen_Intermediate|Control_saline / Treatment groups by lineage, cell group, cell type | 8.90e-05 | 200 | 161 | 6 | 041a34080120c9f613373c20dcc366292f558040 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.90e-05 | 200 | 161 | 6 | 89821a264e872ed53e08e9d3609d5cc5c314503e | |
| ToppCell | (6)_Stroma|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 8.90e-05 | 200 | 161 | 6 | f9baef67dde62f1c161a9408a78f635ea70ea9d3 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.90e-05 | 200 | 161 | 6 | 70a06fd7fb8de2c8ec3e3182e4476ced049daeae | |
| ToppCell | (6)_Stroma|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 8.90e-05 | 200 | 161 | 6 | f0818821c495022569aef2c1886d9f2446dc027e | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 8.90e-05 | 200 | 161 | 6 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.90e-05 | 200 | 161 | 6 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.90e-05 | 200 | 161 | 6 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.90e-05 | 200 | 161 | 6 | 1639982d9d994918f7912d12d9d7cfcbc9da4145 | |
| Drug | 2'-methoxyacetophenone | 3.47e-07 | 3 | 161 | 3 | CID000068481 | |
| Drug | N-nitrosomethylaniline | 2.28e-06 | 14 | 161 | 4 | CID000011957 | |
| Drug | N6-methyladenosine [1867-73-8]; Down 200; 14.2uM; HL60; HT_HG-U133A | 9.47e-06 | 192 | 161 | 9 | 1271_DN | |
| Drug | Spaglumic acid [4910-46-7]; Down 200; 13.2uM; HL60; HT_HG-U133A | 1.07e-05 | 195 | 161 | 9 | 2962_DN | |
| Drug | Telenzepine dihydrochloride [147416-96-4]; Down 200; 9uM; HL60; HT_HG-U133A | 1.12e-05 | 196 | 161 | 9 | 2388_DN | |
| Drug | geldanamycin | TET2 MBTD1 COL12A1 SETX VPS50 JMJD1C ZNF518A ESCO2 SETD2 EGF CDK13 NRK | 1.39e-05 | 371 | 161 | 12 | ctd:C001277 |
| Drug | NSC35549 | 1.60e-05 | 22 | 161 | 4 | CID000411697 | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 1.24e-07 | 3 | 148 | 3 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 1.24e-07 | 3 | 148 | 3 | DOID:0111190 (implicated_via_orthology) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.06e-06 | 152 | 148 | 8 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Periventricular nodular heterotopia | 2.50e-05 | 2 | 148 | 2 | cv:C1868720 | |
| Disease | angiopoietin-related protein 3 measurement | 7.47e-05 | 3 | 148 | 2 | EFO_0020148 | |
| Disease | Malignant neoplasm of breast | THEMIS2 FLNA FLNB ANK2 MAOA TRPC4 PER1 ARFGEF2 SHROOM2 SETD2 EGF ZNF644 DLEC1 KLHDC10 SPEN PDZD4 | 1.03e-04 | 1074 | 148 | 16 | C0006142 |
| Disease | Systemic mastocytosis with associated clonal, hematologic non-mast-cell lineage disease | 1.49e-04 | 4 | 148 | 2 | C1301365 | |
| Disease | Sotos' syndrome | 1.49e-04 | 4 | 148 | 2 | C0175695 | |
| Disease | mean reticulocyte volume | MYO9B FBRSL1 NEB ZHX2 JMJD1C REXO1 USP8 ZNF469 SCG3 BRD4 PPA2 AKAP13 EPB41 | 2.04e-04 | 799 | 148 | 13 | EFO_0010701 |
| Disease | Malignant Cystosarcoma Phyllodes | 2.47e-04 | 5 | 148 | 2 | C0600066 | |
| Disease | Myelodysplastic syndrome | 2.47e-04 | 5 | 148 | 2 | cv:C3463824 | |
| Disease | MYELODYSPLASTIC SYNDROME | 2.47e-04 | 5 | 148 | 2 | 614286 | |
| Disease | chronic myelomonocytic leukemia (is_implicated_in) | 2.47e-04 | 5 | 148 | 2 | DOID:0080188 (is_implicated_in) | |
| Disease | Phyllodes Tumor | 2.47e-04 | 5 | 148 | 2 | C0010701 | |
| Disease | reticulocyte measurement | FLNA FLNB BMP2K MYO9B ZCCHC8 PER1 ARFGEF2 JMJD1C SH3D21 ZNF469 EGF BRD4 AKAP13 ASXL2 EPB41 | 2.77e-04 | 1053 | 148 | 15 | EFO_0010700 |
| Disease | Prostatic Neoplasms | TET2 CYP2A6 ARID4A LMTK2 JAK1 SETD2 EGF BRD4 AKAP13 CHD6 SPEN | 2.91e-04 | 616 | 148 | 11 | C0033578 |
| Disease | Malignant neoplasm of prostate | TET2 CYP2A6 ARID4A LMTK2 JAK1 SETD2 EGF BRD4 AKAP13 CHD6 SPEN | 2.91e-04 | 616 | 148 | 11 | C0376358 |
| Disease | Autistic Disorder | 3.62e-04 | 261 | 148 | 7 | C0004352 | |
| Disease | periventricular nodular heterotopia (is_implicated_in) | 3.70e-04 | 6 | 148 | 2 | DOID:0050454 (is_implicated_in) | |
| Disease | Severe major depression with psychotic features | 3.70e-04 | 6 | 148 | 2 | C0270458 | |
| Disease | Periventricular Nodular Heterotopia | 5.16e-04 | 7 | 148 | 2 | C1868720 | |
| Disease | Polycythemia Vera | 6.86e-04 | 8 | 148 | 2 | C0032463 | |
| Disease | Colorectal Carcinoma | TET2 CYP2A6 FLNC ANK2 PER1 ARHGEF10L PPOX NLGN4X STRAP CCNB3 CAMSAP2 | 8.61e-04 | 702 | 148 | 11 | C0009402 |
| Disease | idiopathic pulmonary fibrosis (is_implicated_in) | 8.79e-04 | 9 | 148 | 2 | DOID:0050156 (is_implicated_in) | |
| Disease | coffee consumption measurement, tea consumption measurement | 1.41e-03 | 44 | 148 | 3 | EFO_0006781, EFO_0010091 | |
| Disease | platelet component distribution width | THEMIS2 BMP2K MYO9B JMJD1C SVEP1 SETD2 EGF DOCK7 AKAP13 DLEC1 EPB41 | 1.54e-03 | 755 | 148 | 11 | EFO_0007984 |
| Disease | Night blindness, congenital stationary, type 1 | 1.60e-03 | 12 | 148 | 2 | C3501847 | |
| Disease | nicotine metabolite ratio | 1.60e-03 | 12 | 148 | 2 | EFO_0007794 | |
| Disease | Night Blindness, Congenital Stationary, Type 1A | 1.60e-03 | 12 | 148 | 2 | C3495587 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder) | 1.60e-03 | 12 | 148 | 2 | C1864877 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B | 1.60e-03 | 12 | 148 | 2 | C1850362 | |
| Disease | X-Linked Csnb | 1.60e-03 | 12 | 148 | 2 | C3711543 | |
| Disease | Sudden infant death syndrome | 1.60e-03 | 12 | 148 | 2 | C0038644 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A | 1.60e-03 | 12 | 148 | 2 | C1848172 | |
| Disease | Adenoid Cystic Carcinoma | 1.64e-03 | 100 | 148 | 4 | C0010606 | |
| Disease | red blood cell density measurement | TET2 SHROOM3 BMP2K FBRSL1 ARFGEF2 RBKS RBBP8NL JMJD1C KIF20B PNPLA1 BRD4 AKAP13 | 1.65e-03 | 880 | 148 | 12 | EFO_0007978 |
| Disease | myopathy (implicated_via_orthology) | 1.81e-03 | 48 | 148 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | prostate carcinoma | TET2 SHROOM3 ANK2 MYO9B FBRSL1 LMTK2 RNF213 RBBP8NL SHROOM2 STXBP1 EGF SPEN | 1.83e-03 | 891 | 148 | 12 | EFO_0001663 |
| Disease | reaction time measurement | 1.85e-03 | 658 | 148 | 10 | EFO_0008393 | |
| Disease | Cone-rod synaptic disorder, congenital nonprogressive | 1.88e-03 | 13 | 148 | 2 | C4041558 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 1.92e-03 | 49 | 148 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | Intellectual Disability | 1.94e-03 | 447 | 148 | 8 | C3714756 | |
| Disease | coffee consumption measurement | 2.29e-03 | 182 | 148 | 5 | EFO_0006781 | |
| Disease | insulin measurement | 2.34e-03 | 267 | 148 | 6 | EFO_0004467 | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 2.51e-03 | 15 | 148 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | alcohol use disorder (is_implicated_in) | 2.86e-03 | 16 | 148 | 2 | DOID:1574 (is_implicated_in) | |
| Disease | Night blindness, congenital stationary | 3.23e-03 | 17 | 148 | 2 | C0339535 | |
| Disease | vital capacity | TET2 SHROOM3 TCP11 ZCCHC8 PER1 ARFGEF2 GMPR2 ZHX2 JMJD1C SVEP1 TRIM66 HMCN1 BRD4 EIF2AK3 | 3.81e-03 | 1236 | 148 | 14 | EFO_0004312 |
| Disease | mean corpuscular hemoglobin concentration | BMP2K ARID4A MYO9B POLR2A FBRSL1 ARFGEF2 GMPR2 NEB EGF BRD4 AKAP13 ASXL2 EPB41 | 3.84e-03 | 1105 | 148 | 13 | EFO_0004528 |
| Disease | monocyte percentage of leukocytes | 3.91e-03 | 731 | 148 | 10 | EFO_0007989 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 4.04e-03 | 19 | 148 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | caffeine metabolite measurement | 4.04e-03 | 19 | 148 | 2 | EFO_0007872 | |
| Disease | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | 4.06e-03 | 398 | 148 | 7 | EFO_0003756, EFO_0003888, EFO_0004337 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Positive | 4.35e-03 | 131 | 148 | 4 | C4704862 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Negative | 4.35e-03 | 131 | 148 | 4 | C4552091 | |
| Disease | Juvenile arthritis | 4.35e-03 | 131 | 148 | 4 | C3495559 | |
| Disease | Juvenile psoriatic arthritis | 4.35e-03 | 131 | 148 | 4 | C3714758 | |
| Disease | Disorder of eye | 4.40e-03 | 212 | 148 | 5 | C0015397 | |
| Disease | Juvenile-Onset Still Disease | 4.84e-03 | 135 | 148 | 4 | C0087031 | |
| Disease | testosterone measurement | TET2 SHROOM3 AMER1 ANK2 ZNF280D MYO9B POLR2A JMJD1C REXO1 MLYCD HMCN1 PPA2 MINAR1 TPH1 | 5.00e-03 | 1275 | 148 | 14 | EFO_0004908 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| THVPIPKSADKVTDK | 311 | Q6UXB8 | |
| PTSEHLSELKKEAPA | 731 | Q6N043 | |
| KHPSLKPSTEVEDPA | 331 | Q5TYW2 | |
| PRKDVHEITSDTAPK | 226 | Q4LE39 | |
| PATEPLHDFVIKKVA | 521 | P54793 | |
| VKSEIPTKDVPIVHT | 746 | P11171 | |
| PTKDVPIVHTETKTI | 751 | P11171 | |
| PHSKAAPGDVKVKEE | 846 | Q9HCM7 | |
| DGAEPPVLTTHLKKV | 26 | Q9H172 | |
| KPEVEVEPAKHRVSF | 186 | Q9HCE6 | |
| TSEKLEGKEPHPQDS | 131 | Q92870 | |
| TNPEHFGTPVIAKKT | 126 | P29374 | |
| TTNGKIEESPEKPSH | 901 | Q9BXX2 | |
| INGKHLVTTVPKDPE | 1411 | P13611 | |
| IPAEHVVTDSPIKKE | 2216 | P13611 | |
| SDGSLEKHPEVPSAK | 2461 | P13611 | |
| EKHPEVPSAKAVTAD | 2466 | P13611 | |
| EPEIGHLSPSKKETI | 226 | Q8N5R6 | |
| QSPKDIDVSPKHVGF | 466 | P11509 | |
| LKVKEAHETAPAPLE | 1806 | Q68DQ2 | |
| DPFATKEHIEIIAPS | 701 | Q9NZJ5 | |
| KEEKIHSPIIRSEPF | 1111 | O60885 | |
| EKPRHKSDVEIPATV | 396 | Q9UEY8 | |
| KHPSLKPSTEVEDPA | 331 | Q4UJ75 | |
| PSQKEKGTATPELHT | 806 | Q12802 | |
| KPTTPEKTDLTNGEH | 241 | Q9Y6D5 | |
| LEEPHSPETGEKVVA | 281 | Q5JTC6 | |
| EHFEGTVTKVIPKVP | 261 | O75534 | |
| PEHPEVTSLKTFVEK | 156 | Q9Y5C1 | |
| VPFISHSGSPEKKAE | 681 | Q9NSY1 | |
| GKVSEKVSAHTPLDP | 131 | Q2NKX9 | |
| PLTPSIGAKEKEQHV | 586 | Q14004 | |
| TIESVHTEKPQPTKE | 551 | Q8IXJ9 | |
| SVPSPAHIEKLDNEK | 791 | Q76L83 | |
| DTHDGPPKEIKLPTS | 11 | Q8IWF9 | |
| LKEPTIDTEAHFKEP | 816 | Q8WWL7 | |
| HFEPIVSLPEVEVKS | 2911 | P49792 | |
| VSEKKPATEVDPTHF | 856 | P23458 | |
| PKHIPTEKVKAVDTT | 251 | Q9H477 | |
| KHPSLKPSTEVEDPA | 331 | Q5SQ80 | |
| KTEKHLPVSPSGKTE | 1956 | Q01484 | |
| PESKDVPAVEITHTF | 476 | P21397 | |
| EGKVERVPKSPEHSA | 1546 | Q9ULH0 | |
| KKTTTPEGEVVPIHQ | 231 | Q15842 | |
| TPPHLFAKVKEVDQS | 366 | Q05BQ5 | |
| KTGSFPEHITQEKAP | 1921 | Q6PRD1 | |
| DEHFKTSPKIPGIDL | 446 | Q15034 | |
| TGHEGKASPPTELVK | 56 | A1A4Y4 | |
| VDTHKIKSSPSPEVV | 631 | Q15652 | |
| EHPPSETEEKNKITA | 271 | O95822 | |
| PSTHTENELKEKKFP | 5131 | Q5CZC0 | |
| DKHIPGSPFTAKITD | 1896 | O75369 | |
| AETSHALVPKEIPGK | 71 | Q96BY2 | |
| STIVHVGDKKPPESD | 726 | O15534 | |
| EIATKPHEKIGFPAA | 301 | Q6PID8 | |
| SEPKKHELSDISELP | 446 | Q76G19 | |
| LHGKEEIKVIPTPSA | 321 | P35913 | |
| VDPSHDASKVKAEGP | 861 | Q14315 | |
| QDEPPAKKGSIHVSS | 841 | Q96Q89 | |
| PSHIEKPTFAEIIEE | 941 | Q6AI08 | |
| PKSAVPLVHVKETVS | 471 | Q8N8W4 | |
| PKESVITGHFEKEKP | 676 | Q8IWU2 | |
| PKKPEHTLVLLDTEG | 86 | P32456 | |
| PKKPEHTLVLLDTEG | 86 | Q9H0R5 | |
| KTVEVPFKGDVEHTI | 291 | Q9P2T1 | |
| PEGLTKTEKIESEIH | 276 | Q05C16 | |
| QHPFSSADVKPKVED | 46 | Q9C091 | |
| SHPQELKTDPKGVFV | 1266 | O75161 | |
| KEFEVTVHVPPTIKS | 1816 | Q96RW7 | |
| KEKLFHFTEETPEIP | 261 | Q16827 | |
| DDIPFEKHVASLAKP | 116 | Q5T2D3 | |
| KDPHKTGPEDTTVLI | 651 | Q8NFZ3 | |
| EEKPAGHRTSPVAKI | 181 | Q8NC74 | |
| KHPSLKPSTEVEDPA | 331 | Q5VUR7 | |
| KDTAGTVPESKAPKH | 291 | Q711Q0 | |
| TTKRKVIETDPEPAH | 3766 | Q4G0P3 | |
| PLSPKETVESHDKAI | 1901 | Q9Y2F5 | |
| QSPKDIDVSPKHVGF | 466 | Q16696 | |
| PDFHEEIKVKLPATL | 626 | Q96N67 | |
| VKEHTTVKPTEAPTE | 2286 | Q99715 | |
| KVVHPLAQPKAEDDT | 296 | P01133 | |
| HDVKTDTLAEDKPGP | 2576 | Q8TD26 | |
| PIRVKVEPSHDASKV | 861 | P21333 | |
| VEPSHDASKVKAEGP | 866 | P21333 | |
| SPFKVPVHDVTDASK | 1436 | P21333 | |
| AVQITDPEGKPKKTH | 1581 | P21333 | |
| QSPKDIDVSPKHVVF | 466 | P20853 | |
| PKTLTDTLIPEEFHI | 166 | Q5T1B0 | |
| AKLTPTHPSVKGEKE | 471 | Q8N3K9 | |
| KEETKPASPHSVLPD | 1161 | Q8N3K9 | |
| SPASKHIIPKGKDEE | 1551 | Q8N3K9 | |
| EAKTIVPPHVTDSKR | 2331 | Q8N3K9 | |
| VKVHPSAVESAPEKN | 556 | Q4KMG0 | |
| ATLSPAEEEKAKGPH | 101 | Q6IS24 | |
| LPHDPSFAIKKVEDV | 441 | Q56NI9 | |
| FKTPVSITEHPKINE | 1686 | Q14204 | |
| SVHQATKAKPDEPEF | 421 | Q6PJP8 | |
| HPVSSEKVAPTSAEK | 266 | Q7Z2K8 | |
| DSPSPVVLHIEAVFK | 841 | Q9Y238 | |
| LPDETKPRETHVEFS | 406 | Q9P1V8 | |
| HVEFSKEDRPEPIKS | 416 | Q9P1V8 | |
| DVEKPSATDGVPKHQ | 1026 | Q9UJQ4 | |
| KDPHKTGPEDTTVLI | 651 | Q8N0W4 | |
| HNPEEKEIKPFESTV | 1066 | Q08AD1 | |
| PEPEKQTDHTVKIAG | 731 | P28827 | |
| SSPVDLEKHEPVKKF | 441 | Q9UPX6 | |
| KVFPTLDHKPVTVDL | 1401 | Q7Z2Y5 | |
| HKTLQIKDSPPEVAG | 536 | Q5T160 | |
| AEKSPSVHISAPGEK | 716 | Q8N1G1 | |
| PHSKPKTSDIFEADI | 181 | O94763 | |
| VPVKFHDLPSEKPES | 166 | Q8WV83 | |
| QEEEHSSPVKAPSVK | 221 | A4FU49 | |
| HVLEKEKTRPEGEPS | 106 | Q9BRT9 | |
| AKSKPIIAEPEIHGA | 261 | Q15750 | |
| FHAEPTVIEKEIKIP | 916 | O15061 | |
| PQKKHLEKETPETSG | 391 | Q92901 | |
| AGPPTKEVRKVHFDT | 121 | Q7Z5V6 | |
| PETIKAKHGSPATDD | 1421 | Q7Z333 | |
| PIKIVHSESQPEKES | 1211 | Q13796 | |
| HDLLSPVEKKPEATA | 536 | Q8TF72 | |
| KRKTSIDPSPESHEV | 1081 | Q562F6 | |
| FTPEIGKKKHTESTP | 106 | Q6UW49 | |
| TAIEKPEEFGKHPES | 206 | Q6UW49 | |
| SPFHDIPLKVNSKEE | 61 | Q9H2U2 | |
| EKSVHSLISDFKDPP | 81 | P61764 | |
| EESVVPPASLGHIKK | 1171 | Q4LDE5 | |
| KPEAEPKEISGHTSG | 131 | Q9Y3F4 | |
| KTGVFEEKHAKPPDV | 201 | O14967 | |
| SHKSPVLDTKPKETG | 461 | Q96S66 | |
| PSEGNEPSTKELKEH | 61 | Q96Q45 | |
| EPSTKELKEHPEAPV | 66 | Q96Q45 | |
| KPRGKEPDETVHSFA | 136 | P50336 | |
| KHVVPLPDGKSTDFL | 596 | Q63HN8 | |
| PPSSLEGKVKETVHN | 76 | Q8WWU5 | |
| LTAAEERKEKVPSPH | 696 | Q96JG6 | |
| KHGDPIPKVEFTEEE | 156 | P17752 | |
| SKTEDHEEAGPLPTK | 301 | Q9BXS4 | |
| SEGSPVLPHEPAKVK | 766 | Q9UKE5 | |
| ESIPKPVHTRFKDDD | 21 | Q6NZY4 | |
| PEVPEIFTKKSEAGH | 581 | Q6NZY4 | |
| KKVVAPVESHVPESN | 2346 | Q96T58 | |
| KTHKDSDVVPFRETP | 336 | Q9BYB0 | |
| VGDISPKSSPHEVKF | 586 | Q9UQR0 | |
| PTQVISKPESKEEHA | 296 | Q9BSI4 | |
| PSDLHPIKVVEGVKE | 1001 | P24928 | |
| LPTFHTEVAEPLKVD | 281 | Q6VEQ5 | |
| SPTGKEPVTKEAPHQ | 16 | Q86XF7 | |
| DVLHPGKATVPKTEI | 26 | P62847 | |
| KVVAKDTSHPTDPLT | 456 | Q5TEJ8 | |
| KFKVEIILDPETAHP | 291 | A6NK02 | |
| VTVAHKKAPPALIDE | 181 | Q86TI0 | |
| LPTFHTEVAEPLKVD | 281 | A8K0Z3 | |
| IVGKEEIPTHSFSPE | 186 | Q86UB9 | |
| KLFEETGHEDPITKT | 426 | Q4J6C6 | |
| SHPEVLGTTIKSPDK | 586 | Q6AHZ1 | |
| KLEFLHKTPVEEVPA | 936 | Q15393 | |
| VPEFTPKSGVKIHVS | 796 | P22314 | |
| LGHPNSEETVKAKIP | 1181 | Q9BYW2 | |
| KEVHSGVSTDPQPLK | 186 | P0DTU4 | |
| TEHEVDVKTPASKPR | 2551 | Q96JG9 | |
| TVFVPPEKHEKEIIA | 801 | Q9BZF9 | |
| TNEETVDKAPPHSKI | 271 | Q9H582 | |
| KKPEEITPENHVEGT | 201 | Q9Y6X8 | |
| HSKLGPSVPNKTEET | 1166 | Q9ULD9 | |
| KAPIIPHSGSIEKAE | 216 | Q96NB3 | |
| PDHPVLASIKKEQET | 496 | Q8N680 | |
| KKDPAHYTTPEEVVS | 1096 | O15016 | |
| VDHKVPKSIGTVPAD | 266 | Q14679 | |
| GKKVKREPAEPHETS | 1946 | Q6N021 | |
| PSIFTLHKKTDIGEE | 131 | Q9BR84 | |
| PTPEIQKKSTGDVPH | 576 | P40818 | |
| ISKLFPAPSEKSHEE | 351 | Q8WXD2 | |
| ETPPATEKAEHSELK | 291 | Q13487 | |
| VVEDTVPIIPKEKHA | 936 | Q9UBN4 | |
| EESEPHGSLLEKFPK | 16 | Q96NJ6 | |
| TLPPQKTVAAESHEK | 1126 | Q13459 | |
| HPDKTKFTQVTDSPV | 496 | P20929 |